CX NEWS
CX 2024: A dynamic force shaping the global vascular community
The CX 2024 venous programme has “a lot to look forward to” Register today to secure your place at the CX 2024 Venous & Lymphatic Controversies sessions taking place on Wednesday, 24 April in [...]
CX 2024: New data and heated debates set to spark controversy in CX peripheral arterial programme
Andrew Holden (Auckland, New Zealand) CX Co-Chair and member of the Peripheral Executive Board highlights the top sessions coming in the CX Peripheral Controversies Update. Register today to secure your place at the CX [...]
CX 2024: Aortic Programme forefronts cutting-edge edited cases “on film” and multiple top-notch debates
Tilo Kölbel (vascular surgeon from Hamburg, Germany, and a member of the Executive Board for the Aortic Programme) makes the case for moving images that will "easily transport" vascular surgeons and interventionalists. He also has his eye [...]
CX 2024: Brand new data on cyanoacrylate glue, bioprosthetic valves and intensive pulmonary embolism treatments
Manj Gohel (Cambridge, UK) and member of the Venous Executive Board parachutes straight into the CX Venous and Lymphatics Controversies Programme to highlight the VenaSeal SPECTRUM programme, SAVVE trial and SYNCHRONOUS trial, which [...]
CX 2024: Get a ringside seat for the big BASIL-3 data reveal
No more freestyling, reset your endovascular CLTI practice with new Level 1 evidence Andrew Bradbury (Birmingham, UK) and the BASIL-3 team of triallists will be presenting, for the very first time, the results [...]
45 Year Legacy of CX Vascular Education Continues
Three newly appointed Charing Cross International Symposium (CX) Co-chairs will ensure Roger Greenhalgh’s inspiring legacy of vascular education continues at CX 2024 with the 46th CX Symposium. Dittmar Böckler (Heidelberg, Germany), Andrew Holden (Auckland, [...]